Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease

Dorrell, L; Fulton, B; Ong, E L C; Ong, E L
June 1994
Thorax;Jun1994, Vol. 49 Issue 6, p620
Academic Journal
journal article
No abstract available.


Related Articles

  • Azithromycin in the Treatment of Legionella Pneumonia Requiring Hospitalization. Plouffe, Joseph F.; Breiman, Robert F.; Fields, Barry S.; Herbert, Mark; Inverso, Jill; Knirsch, Charles; Kolokathis, Antonia; Marrie, Thomas J.; Nicolle, Lindsay; Schwartz, Douglas B. // Clinical Infectious Diseases;12/1/2003, Vol. 37 Issue 11, p1475 

    Azithromycin is highly active against Legionella pneumophila and has been shown to be efficacious in animal models and in clinical studies of patients with legionnaires disease. This open, prospective, multicenter trial evaluated azithromycin for the treatment of legionnaires disease....

  • Immunosuppressants/tumour necrosis factor inhibitors.  // Reactions Weekly;1/21/2012, Issue 1385, p24 

    The article presents case reports of 24 patients who developed Legionnaires' disease while receiving tumour necrosis factor (TNF) inhibitors and immunosuppressant therapy.

  • Treatment of Legionnaires’ Disease. Amsden, Guy W. // Drugs;2005, Vol. 65 Issue 5, p605 

    Legionnaires’ disease is pneumonia, usually caused by Legionella pneumophila, which can range in severity from mild to quite severe. While it is commonly acquired in the community, it can just as easily be acquired nosocomially from water sources that have not been appropriately...

  • Legionella Lives. Springston, Jack // Engineered Systems;Jan2000, Vol. 17 Issue 1, p80 

    Offers information on Legionnaire's disease and Pontiac fever in the United States which are caused by the Legionella pneumophila bacteria. Ecology of the bacteria; Symptoms; Host-specific risk factors; Hospitalization of patients with appropriate antibiotic therapy; Presence of the bacteria in...

  • Legionnaires' Disease at a Dutch Flower Show: Prognostic Factors and Impact of Therapy. Lettinga, Kamilla D.; Verbon, Annelies; Weverling, Gerrit-Jan; Schellekens, Joop F.P.; Den Boer, Jeroen W.; Yzerman, P.F.; Prins, Jacobus; Boersma, Wim G.; van Ketel, Ruud J.; Prins, Jan M.; Speelman, Peter // Emerging Infectious Diseases;Dec2002, Vol. 8 Issue 12, p1448 

    Provides information on a study which determined risk factors for intensive care unit admission and death related to the outbreak of Legionnaires' disease in the Netherlands. Mortality rate of the disease; Therapy administered to the patients; Application of the urinary antigen test on the...

  • Comparative Tolerability of Intravenous Erythromycin and Clarithromycin in Hospitalised Patients with Community-Acquired Pneumonia: Results of a Double-Blind, Randomised, Prospective Study. de Celis, G.; Gea, E.; Roig, J.; Latorre, X.; Martínez-Benazet, J.; Gómez, J. // Clinical Drug Investigation;2002, Vol. 22 Issue 6, p393 

    The role of intracellular pathogens as causative agents of community-acquired pneumonia (CAP), especially Legionella spp. in the case of severe CAP, has supported the use of macrolides as one of the recommended options in most international guidelines for treating CAP that requires hospital...

  • Azithromycin for PID beats doxycycline on all counts. Rowland, Kate; Ewigman, Bernard // Journal of Family Practice;Dec2007, Vol. 56 Issue 12, p1006 

    The article focuses on the effectiveness of azithromycin, an azalide, for patients with mild pelvic inflammatory disease (PID). It presents a comparison study of azithromycin and doxycycline for PID. It is stated that azithromycin is known to be effective therapy of Chlamydia trachomatis...

  • Mysterious Fever in Philly.  // Current Health 1;Nov2004, Vol. 28 Issue 3, p2 

    Provides information on Legionnaires' disease.

  • The Compromised Host and Legionnaires' Disease. Saravolatz, Louis D.; Burch, Keith H.; Fisher, Evelyn; Madhavan, Tom; Kiani, Daria; Neblett, Thomas; Quinn, Edward L. // Annals of Internal Medicine;Apr79, Vol. 90 Issue 4, p533 

    Presents information on a study that described the clinical features, diagnostic methods, therapy and outcome of Legionnaires' disease in immunosuppressed patients at Henry Ford Hospital. Research methods; Results and discussion on the study.

  • Legionnaires' Disease: Unusual Clinical and Laboratory Features. Meyer, Richard D.; Edelstein, Paul H.; Kirby, Barbara D.; Louie, Milton H.; Mulligan, Maury E.; Morgenstein, Alan A.; Finegold, Sydney M. // Annals of Internal Medicine;Aug80, Vol. 93 Issue 2, p240 

    Presents case studies which investigated the clinical and laboratory features of Legionnaires' disease in patients. Etiology of Legionnaires' disease; Medical history of the patients; Relevance of rapid diagnostic methods.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics